Search

Search Constraints

You searched for: Author/Creator Tu, Ly

Search Results

1. Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis. Issue 11 (17th October 2017)

2. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension. Issue 2 (18th July 2018)

3. Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension. Issue 3 (27th November 2018)

4. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats. Issue 3 (7th June 2019)

5. Lineage Tracing Reveals the Dynamic Contribution of Pericytes to the Blood Vessel Remodeling in Pulmonary Hypertension. Issue 3 (March 2020)

6. Therapeutic potential of melatonin and melatonergic drugs on K18‐hACE2 mice infected with SARS‐CoV‐2. Issue 1 (15th October 2021)

7. Dasatinib increases endothelial permeability leading to pleural effusion. Issue 1 (18th January 2018)

8. Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10. Issue 7 (4th June 2021)

9. Driving Role of Interleukin‐2–Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic Sclerosis. Issue 8 (28th June 2022)

10. Mineralocorticoid Receptor Antagonism by Finerenone Attenuates Established Pulmonary Hypertension in Rats. Issue 10 (18th August 2022)